Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator

Circulation. 2026 Apr 28;153(17):1343-1346. doi: 10.1161/CIRCULATIONAHA.125.077634. Epub 2026 Apr 27.
No abstract available

Keywords: cardiography, impedance; defibrillators, implantable; heart failure; sodium-glucose transporter 2 inhibitors.

Publication types

  • Letter